Research Archives

UNC researchers are recruiting North Carolinians for a study to see whether a blood test could detect 10 types of cancer.

Researchers are investigating a new way to tackle bone cancer while minimizing toxicity typically associated with chemotherapy.

Backed by results from the OPTIMA trial, the Prosigna Breast Risk of Recurrence (ROR) test offers a new way to personalize treatment and reduce unnecessary chemotherapy for patients with breast cancer.

MD/PhD student Kounlavong has received an NCI F30 Predoctoral Fellowship to investigate how the tumor microenvironment shapes treatment vulnerability in bladder cancer, a disease where we still cannot predict which patients will respond to available therapies.

UNC is the only medical institution in the world to use high frequency sound waves to inactivate brain tissue that causes epilepsy.

Researchers conduct new patient registry and radiation therapy study to improve outcomes for patients at high risk of liver cancer and those with early-stage cancer, respectfully

UNC School of Medicine researchers announce how a novel insulin approach shows promise for safer, more stable blood sugar management in type 1 diabetes in the OPTI-2 clinical trial.

UNC School of Medicine researchers report that taking vitamin D orally has repeatedly failed to improve outcomes for people with chronic lung diseases. Inhaling vitamin D directly into the airways could offer a more effective, targeted treatment.

Carolina was named the 18th “Most Innovative Institution” among hundreds of universities across the nation by the Cure Innovation Index.

Researchers mailed the test to recipients across North Carolina and calculated a nearly 20% increase among residents who agreed to take the test, regardless of race or ethnicity.

The genetic tool allows doctors to better tailor treatments to each patient's unique subtype of B-cell acute lymphoblastic leukemia.

The new study, led by researchers in the lab of Blossom Damania, PhD, has identified a new therapeutic target for difficult-to-treat cases of non-Hodgkin lymphoma

Category: Research

Could one blood test detect multiple cancers earlier?

UNC Biochemists Discover New Method to Combat Pediatric Bone Cancer

Hormone Therapy or Chemotherapy? A Test Developed by a UNC Researcher Can Tell You

UNC Lineberger MD/PhD Student Awarded NCI F30 Fellowship for Bladder Cancer Research

Former Marine Undergoes First-of-its-Kind Procedure to Reduce Life-Altering Seizures

UNC Lineberger Researchers Advance Early-Stage Liver Cancer Detection and Treatments

New Liver Targeted Insulin Shows Promise for Safer Type 1 Diabetes Treatment

Targeting Delivery to the Lungs: Inhaled Vitamin D Could Be New Strategy

UNC Recognized as Top University for Research, Market Translation

UNC Study Shows Strong Patient Response to At-Home Colorectal Cancer Screening

UNC Researchers Develop Faster, Low-Cost Method to Diagnose Common Pediatric Cancer

UNC Study Reveals Promising New Therapy for Non-Hodgkin Lymphoma